Skip to main content
Log in

New drug recommendations from NICE

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. PharmaTimes.NICE opens door to Gilead's Viread for hepatitis B. Internet Document: [2 pages], 26 May 2009. Available from: URL: http://www.pharmatimes.com

  2. Pfizer.Pfizer's Sutent is Recommended for Reimbursement for Gastrointestinal Stromal Tumor Patients by British Health Agency. Media Release: 28 May 2009. Available from: URL: http://www.pfizer.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New drug recommendations from NICE. Pharmacoecon. Outcomes News 580, 2 (2009). https://doi.org/10.2165/00151234-200905800-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905800-00003

Keywords

Navigation